Press Releases

DermTech PLA Included in Peer Review Article of Novel Molecular Technologies for Melanoma Management with Potential to Address Current Gaps in Diagnostic Accuracy and Prognostication

Profacgen Released Lactic Acid Bacteria Fermentation Service

Creative BioMart Introduced Protein Network Construction and Topological Structure Analysis Service

Matexcel Updated Its Metal Powder Products Recently

EchelonDx Launches Mobile COVID-19 Testing and Vaccination Verification Application to Help Reopen Local Businesses, Restore Employment and Revive Economic Growth

Echelon Diagnostics launched the SafeKey™ Health Passport, a new mobile enterprise COVID-19 testing and vaccination verification application.

Accumen Develops New Channels for Critical COVID-19 Supplies and Recovery Resources for Hospitals and Health Systems

Accumen’s COVID-19 Resource Center provides access to its new testing capacity network, supplies of nasopharyngeal swabs, and face shields, as well as rapid response performance tools for hospital lab and imaging departments.

COVID-19 Total Antibody Test from Ortho Clinical Diagnostics Receives CE Mark

Proof-of-Concept Research Demonstrates Patients Reliably Perform Remote Self-Sampling of Concerning Moles Using DermTech’s Non-Invasive Adhesive Skin Collection Kit Under Physician Supervision via Telemedicine

DermTech Announces Telemedicine Solution to Enable Remote Use of its Non-Invasive Adhesive Patch Test for Melanoma Detection

Ortho Clinical Diagnostics and Quest Diagnostics to Broaden Availability of COVID-19 Antibody Testing

BioIVT Introduces High-purity Kupffer Cells to Support Drug Discovery and Development for Liver Diseases and Help Predict Adverse Drug Reactions

Dysregulation of the Kupffer cell response contributes to liver diseases such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and liver fibrosis.

Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system

Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system for preclinical research.

Halfpenny Technologies, an Accumen Company, Launches COVID-19 Test Capacity and Routing Network Across 870 U.S. Hospitals to Accelerate Diagnostic Testing

This network uses a secure, cloud-based hub-and-spoke approach to process COVID-19 test orders and direct them efficiently to the nearest laboratory with capacity. 

Ubiquitome targets testing travellers for COVID-19

UK medtech firm receives significant investment to help development of Covid-19 test

UK medtech company Bond Digital Health has received significant equity funding to develop the digital element of a new rapid test to support authorities fighting the coronavirus pandemic.Bond is part of an international consortium that is producing a lateral flow based diagnostic test for patients suspected of having Covid-19

VERICHEM LABORATORIES OFFERS LIQUID STABLE, GRAVIMETRIC STANDARDS CONTAINING LEVELS OF BOTH AMMONIA AND IRON

Liquid stable reference standards, containing both Ammonia and Iron concentrations, and explicitly manufactured to meet the needs of a variety of laboratory professionals, are now offered from VERICHEM LABORATORIES.

GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-CoV-2 (COVID-19) Vaccine Development

The New Technology CAR-T Is Expected to Overcome AIDS After Being Transformed

HIV continues to be a major global public health issue, having claimed more than 32 million lives so far. However, the increasing access to effective HIV prevention, diagnosis and treatment has made it less threatening. Recently, convertibleCAR-T cell has been a hot issue for its great power to kill HIV-infected cells.

Creative Diagnostics Launches SARS-CoV-2 Antigens and Antibodies for Research Use

Creative Diagnostics launches SARS-CoV-2 antigens and antibodies for global researchers.

Independent site management organisation Panthera expands vaccine trial capacity

Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UK.